Patents by Inventor Oscar Krijgsman

Oscar Krijgsman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Means and methods for molecular classification of breast cancer
    Patent number: 10072301
    Abstract: The invention relates to a method of typing a sample from a breast cancer patient. More specifically, the invention relates to a method for classification of breast cancer according to the presence or absence of Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth factor Receptor 2 (ERBB2; HER2). More specifically, the invention provides methods and means to classify breast cancer as ER positive, triple negative (ER?, PR? and HER2?) and HER2+.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: September 11, 2018
    Assignee: Agendia N.V.
    Inventors: Oscar Krijgsman, Paul Roepman, Annuska Maria Glas
  • MEANS AND METHODS FOR MOLECULAR CLASSIFICATION OF BREAST CANCER
    Publication number: 20160115552
    Abstract: The invention relates to a method of typing a sample from a breast cancer patient. More specifically, the invention relates to a method for classification of breast cancer according to the presence or absence of Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth factor Receptor 2 (ERBB2; HER2). More specifically, the invention provides methods and means to classify breast cancer as ER positive, triple negative (ER?, PR? and HER2?) and HER2+.
    Type: Application
    Filed: October 28, 2015
    Publication date: April 28, 2016
    Inventors: Oscar Krijgsman, Paul Roepman, Annuska Maria Glas
  • Means and methods for molecular classification of breast cancer
    Patent number: 9175351
    Abstract: The invention relates to a method of typing a sample from a breast cancer patient. More specifically, the invention relates to a method for classification of breast cancer according to the presence or absence of Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth facto Receptor 2 (ERBB2; HER2). More specifically, the invention Provides methods and means to classify breast cancer as ER positive, triple negative (ER?, PR? and HER2?) and HER2+.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: November 3, 2015
    Assignee: AGENDIA N.V.
    Inventors: Oscar Krijgsman, Paul Roepman, Annuska Maria Glas
  • MEANS AND METHODS FOR MOLECULAR CLASSIFICATION OF BREAST CANCER
    Publication number: 20130178381
    Abstract: The invention relates to a method of typing a sample from a breast cancer patient. More specifically, the invention relates to a method for classification of breast cancer according to the presence or absence of Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth factor Receptor 2 (ERBB2; HER2). More specifically, the invention provides methods and means to classify breast cancer as ER positive, triple negative (ER?, PR? and HER2?) and HER2+.
    Type: Application
    Filed: July 11, 2012
    Publication date: July 11, 2013
    Inventors: Oscar Krijgsman, Paul Roepman, Annuska Maria Glas